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Abstract 
BACKGROUND: Differentiating between unstable angina and myocardial infarction (MI) is clinically important as 
they require different treatments. High sensitivity C-reactive protein (hs-CRP) has recently been recognized as 
prognostic factor in acute coronary syndrome. Since this biomarker may indicate the prognosis of heart disease, 
identifying its diagnostic value will be clinically important. This study investigated the diagnostic value of the level 
of hs-CRP in differentiating MI from unstable angina.  
METHODS: Blood samples were obtained from all patients with suspected MI or unstable angina at the time of 
referral. The patients were put in one of the two groups based on final diagnosis. The exclusion criteria were 
infectious diseases, immune system diseases, history of a recent surgery or trauma, kidney failure, liver failure, 
cancers, and use of anti-inflammatory drugs. Data was entered in SPSS and analyzed by independent t, Mann-
Whitney U and chi-square or Fisher’s exact tests. ROC curve was used to determine hs-CRP cut-off point. The 
sensitivity and specificity were calculated at the cut-off point. 
RESULTS: Overall, 60 patients (30 patients with MI and 30 patients with unstable angina) were studied. Hs-CRP 
level was 3.68 ± 0.86 mg/l in patients with MI and 2.35 ± 1.30 mg/l in patients with unstable angina  
(P < 0.001). The best cut-off point for differentiating unstable angina from MI was hs-CRP levels equal to or greater 
than 3.27 mg/l. At this cutoff point, the sensitivity and specificity were both 77%. 
CONCLUSION: Patients with MI had higher levels of hs-CRP than subjects with unstable angina. Hs-CRP levels 
equal to or higher than 3.27 mg/l are more likely to be associated with MI. It is recommended to test this 
biomarker in all patients with acute coronary syndrome. 
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Introduction1 
Inflammatory marker proteins have been used as 
a noninvasive method to assess atherosclerosis 
and prognosis of patients. High sensitivity  
C-reactive protein (hs-CRP) is an inflammatory 
marker which has received great attention 
                                                 
Corresponding Author: 
Katayoon Haddadian 
Email: katyhad@ymail.com 
recently.1-5 Many studies have evaluated the 
relationship between this biomarker and the 
incidence and prognosis of cardiovascular 
diseases. While some of these studies have 
suggested an association between hs-CRP and 
prognosis and mortality of patients, others have 
suggested opposite results.6-10 According to a 
number of studies, hs-CRP concentrations more 
than 3 mg/l is more associated with disease 
outcome and may worsen the prognosis in 
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patients with acute coronary syndrome (ACS).11-13 
Research on the value of hs-CRP in the 
diagnosis of ACS has also reported controversial 
results.14-16 However, studies in this field have 
had shortages and further studies are hence 
warranted. For instance, although it is important 
to differentiate unstable angina from myocardial 
infarction (MI) since they require distinct 
treatments, no study has assessed the diagnostic 
value of hs-CRP in differentiating between these 
two diseases. Considering the fact that increased 
levels of hs-CRP have been suggested to worsen 
the prognosis of cardiovascular diseases, 
evaluating the diagnostic value of this biomarker 
in distinguishing unstable angina from MI may 
be clinically important. Therefore, this study 
investigated the sensitivity and specificity of 
different levels of hs-CRP in differentiating MI 
from unstable angina. 
Materials and Methods 
The study protocol was first approved by ethics 
committee of Kurdistan University of Medical 
Sciences (Sanandaj, Iran). The participants were 
then selected from individuals with chest pain 
who referred to the emergency ward of Tohid 
Hospital (Sanandaj, Iran). Patients were only 
included if the diagnosis of MI or unstable 
angina was confirmed by a cardiologist. The 
subjects were selected through convenience 
sampling until the sample size was reached. 
Blood samples were obtained from all patients 
with suspected MI or unstable angina at the time 
of referral and the participants were categorized 
based on the final diagnosis. The exclusion 
criteria were having an infectious disease in the 
past three weeks, immune system and 
autoimmune diseases, a history of surgery in the 
past two months, a history of trauma in the past 
two months, chronic renal failure, hepatitis, 
cancers, and use of anti-inflammatory drugs. 
Using the formula of differences in the mean and 
having α = 1%, β = 10%, and mean hs-CRP of  
1.7 ± 09 mg/l for MI and 0.93 ± 09 mg/l for 
unstable angina,15 the minimum sample size was 
calculated as 22 subjects in each group. We 
studied 30 patients in each group. 
After explaining the objectives of the study 
to the patients, they were asked to sign the 
consent forms. All patients completed a 
questionnaire and preliminary examinations 
(e.g. blood pressure measurement) were 
conducted under standard conditions.  
Data was entered in SPSS for Windows 
(version 16.0, SPSS Inc., Chicago, IL, USA). 
Kolmogorov-Smirnov test was used to assess 
the normal distribution of quantitative data. 
Quantitative data of the two groups was 
compared with Student’s independent t-test or 
Mann-Whitney test. Chi-square and Fisher’s 
exact tests were used to compare qualitative 
data. Receiver operating characteristic (ROC) 
curve was used to determine hs-CRP cutoff 
point. The sensitivity and specificity were 
calculated at the cutoff point. 
Results 
We studied 30 patients with MI and 30 patients 
with unstable angina (mean age: 59.8 ± 12.9 
years). Females constituted 51.6% of the 
participants (n = 31). Fifteen subject (25.0%) lived 
in rural areas and 14 (23.3%) had a family history 
of MI. Overall, 38 patients (63.3%) were active 
smokers and 14 (23.3%) were non-active smokers. 
History of hypertension, diabetes, and 
hyperlipidemia were reported by 22 (36.6%), nine 
(15.0%), and 16 patients (26.7%), respectively. The 
two groups had no significant differences in any 
variables except smoking. While vomiting was 
significantly more prevalent in the group with 
MI, there was no statistically significant 
differences between the two groups regarding 
other symptoms (Table 1). 
Hs-CRP level was 3.68 ± 0.86 mg/l in patients 
with MI and 2.35 ± 1.30 mg/l in patients with 
unstable angina (P < 0.001). The best cutoff point 
for differentiating unstable angina from MI was 
hs-CRP levels equal to or greater than 3.27 mg/l 
(Figure 1). At this cutoff point, the sensitivity and  
specificity were both 77% (Table 2) and the 
area under the ROC curve was calculated as 0.794 
(95% confidence interval 0.68-0.91; P < 0.001). 
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Table 1. Comparison of characteristics of patients with myocardial infarction (MI) and unstable angina 
Variables MI Unstable Angina P 
Sex    
Male 12 (40) 17 (56.7) 0.196 
Female 18 (60) 13 (43.3)  
Place of residency    
Urban 21 (70.0) 24 (80.0) 0.371 
Rural 9 (30.0) 6 (20.0)  
Family History of MI 7 (23.3) 7 (23.3) 1.000 
Current Smoker 15 (50.0) 23 (76.7) 0.032* 
Passive Smoker 8 (26.7) 6 (20.0) 0.542 
Hypertension 9 (30.0) 13 (43.3) 0.284 
Hyperlipidemia 5 (16.7) 11 (36.7) 0.143 
Diabetes 2 (6.2) 7 (23.3) 0.145† 
Chest pain 27 (90.0) 29 (96.7) 0.612† 
Dyspnea 18 (60.0) 15 (50.0) 0.436 
Sweating 18 (60.0) 14 (46.7) 0.301 
Vomiting 18 (60.0) 8 (26.7) 0.009* 
Level of education** 1 (0-4) 1 (0-4) 0.362§ 
Diabetes duration (year) 1 (1-1) 8 (3-20) 0.040* 
Hypertension duration (year) 9 (3-15) 7 (1-21) 0.689§ 
Hyperlipidemia duration (year) 1 (1-12) 3 (1-16) 0.524§ 
Age (year) 59.9 ± 13.1 59.7 ± 12.9 0.945 
Body mass index (kg/m2) 25.7 ± 3.7 26.5 ± 3.5 0.417†† 
High sensitivity C-reactive protein (mg/l) 3.68 ± 0.86 2.35 ± 1.30 < 0.001††* 
Chest pain duration (hour) 2.50 (0.50-80) 3.00 (0.15-24.00) 0.464§ 
Smoking (Packs/year) 20.50 (0.75-120.00) 19.00 (0.45-100.00) 0.721§ 
Values are expressed as n (%), mean (range), or mean ± SD; †: Fisher’s exact test was applied; ††: Student’s independent t-test 
was applied; §: Mann-Whitney test was applied, Other comparisons were done by chi-square test;* Statistically significant; 
**
 0: Illiterate; 1: Elementary school; 2: Junior high school; 3: High school; 4: College; MI: Myocardial infarction 
 
 
Figure 1. Receiver operating characteristic (ROC) curve to differentiate myocardial  
infarction from unstable angina (The area under the curve was calculated  
as 0.794 for 3.27 mg/l; 95% confidence interval: 0.68-0.91; P < 0.001). 
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Table 2. Calculating sensitivity and specificity 
of different high sensitivity C-reactive protein 
(hs-CRP) levels for differentiating myocardial 
infarction from unstable angina 
Hs-CRP (mg/l) Sensitivity Specificity 
0.22 1.00 0.03 
0.45 1.00 0.07 
0.71 1.00 0.10 
0.85 1.00 0.13 
0.94 1.00 0.17 
1.06 1.00 0.20 
1.22 1.00 0.30 
1.43 1.00 0.40 
1.85 0.93 0.40 
2.15 0.90 0.40 
2.26 0.90 0.43 
2.48 0.90 0.53 
2.65 0.90 0.57 
2.79 0.87 0.57 
2.96 0.83 0.60 
2.99 0.83 0.63 
3.17 0.77 0.63 
3.24 0.77 0.70 
3.27† 0.77 0.77 
3.35 0.73 0.77 
3.48 0.67 0.80 
3.66 0.60 0.80 
3.82 0.60 0.83 
3.93 0.53 0.83 
3.99 0.43 0.83 
4.09 0.33 0.87 
4.19 0.30 0.90 
4.28 0.27 0.90 
4.38 0.23 0.97 
4.48 0.13 0.97 
4.57 0.13 1.00 
4.64 0.10 1.00 
4.70 0.07 1.00 
5.73 0.00 1.00 
† The best diagnostic level; Hs-CRP: High sensitivity  
C-reactive protein 
Discussion 
In this study, patients in both groups had similar 
baseline characteristics. Hs-CRP levels were 
higher in patients with unstable angina than 
patients in those with MI. The cutoff point for 
differentiating between the two diseases was 
calculated as 3.27 mg/l. Accordingly, it seems 
that hs-CRP could be helpful in differentiating 
MI from unstable angina. 
Several studies have recently shown that 
inflammation is one of the mechanisms of 
cardiovascular diseases.4,5 Zairis et al. found that  
hs-CRP level is a predictor of mortality over the 
next five years in patients with ACS7 and that it 
may be associated with MI size.14 Tanaka et al. 
indicated hs-CRP level to be associated with 
atherosclerotic plaque rupture, i.e. higher levels 
were detected in subjects with greater number of 
ruptured atherosclerotic plaques.17 
Most previous studies have investigated the 
prognostic value of hs-CRP in cardiovascular 
diseases and very few have assessed its 
diagnostic value in different heart diseases. It is 
very important to differentiate MI from 
unstable angina and also to differentiate 
unstable angina from stable angina since they 
require different treatment approaches. Thakur 
et al. found hs-CRP levels to be 1.70 ± 0.75 and 
0.93 ± 0.35) mg/l in patients with 
cardiovascular disease and healthy people, 
respectively (P < 0.001).4 Yip et al. reported 
levels of 2.95 mg/l in patients with MI and 1.35 
mg/l in subjects with unstable angina  
(P < 0.001). They found this biomarker to be 
related with disease prognosis and suggested it 
as an indicator of the amount of attention a 
patient has to receive.15 In another study, Yip et 
al. calculated hs-CRP levels as 2.7 and 1.4 mg/l 
in subjects with MI and unstable angina, 
respectively. The values had no relation with 
gender, smoking, diabetes, body mass index 
(BMI), or hypercholesterolemia.18 In contrast, 
Diercks et al. rejected the diagnostic value of 
hs-CRP in differentiating acute coronary 
syndrome from other diseases (area under the 
ROC curve: 0.49).16 Amanvermez et al. reported 
significantly higher level of hs-CRP in patients 
with MI than in those with unstable angina. 
While the area under the ROC curve was 0.6 in 
their study, unfortunately, they did not set a 
cutoff point.19  
As it is seen, the mean levels of hs-CRP have 
been different in previous studies. This might 
have been caused by different sampling 
methods or inclusion/exclusion criteria. The 
higher area under the ROC curve obtained in the 
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present study compared to those calculated by 
Diercks et al.16 and Amanvermez et al. may be 
justified by our careful consideration over the 
exclusion criteria (we eliminated conditions 
which could influence hs-CRP levels). Therefore, 
it is recommended to use hs-CRP level of 3.27 
mg/l to differentiate MI from unstable angina. 
At this cutoff point, the sensitivity and 
specificity are both equal to 77%. Additionally, 
we calculated the sensitivity and specificity of 
various levels of this biomarker. This allows the 
physicians to choose the appropriate level and to 
use suitable diagnostic and treatment 
approaches in different situations. 
Although hs-CRP levels may increase in 
patients affected by atherosclerosis, such 
increase can also be caused by the pathology of 
MI. This provides a means of diagnosing MI. 
This biomarker can be associated with higher 
levels of plaque rupture which is probably a 
reason for its high levels in patients with MI.17 
Patients with unstable angina who have higher 
levels of hs-CRP have also been suggested to be 
at greater risk of mortality and MI.10,20 
Conclusion 
Hs-CRP levels were higher in patients with MI 
than in those with unstable angina. Hs-CPR 
levels of 3.27 mg/l or higher are in favor of MI. 
It is recommended to assess this biomarker in all 
patients with ACS. 
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